Last reviewed · How we verify
[14C]-TEV-56286
At a glance
| Generic name | [14C]-TEV-56286 |
|---|---|
| Also known as | emrusolmin |
| Sponsor | Teva Branded Pharmaceutical Products R&D, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- [14C]-TEV-56286 CI brief — competitive landscape report
- [14C]-TEV-56286 updates RSS · CI watch RSS
- Teva Branded Pharmaceutical Products R&D, Inc. portfolio CI